Aptorum Group Limited
-
Ticker
APM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in London, England
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.
REPORT RATINGS
4.8 / 5.0 (108)
Aptorum Group Limited reports have an aggregate usefulness score of 4.8 based on 108 reviews.
Aptorum Group Limited
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports